Healthcare -
Biotechnology - NASDAQ - US
$ 7.485
-7.02 %
$ 5.21 M
Market Cap
0.0
P/E
RNAZ - STOCK-BASED COMPENSATION
Stock-based Compensation RNAZ - TransCode Therapeutics, Inc.
1.04 M
LAST VALUE
136.11%
2 YEAR CAGR
115.37%
5 YEAR CAGR
0.00%
10 YEAR CAGR